The global market for Genetic Virus Vector was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.

North American market for Genetic Virus Vector is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Asia-Pacific market for Genetic Virus Vector is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The global market for Genetic Virus Vector in Gene Therapy is estimated to increase from $ million in 2024 to $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The major global companies of Genetic Virus Vector include FUJIFILM Diosynth Biotechnologies U.S.A., Sanofi, Lonza, Merck KGaA, GENERAL ELECTRIC COMPANY, Oxford BioMedica, Spark Therapeutics, Inc., uniQure N.V., FinVector Vision Therapies, Brammer Bio, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

This report aims to provide a comprehensive presentation of the global market for Genetic Virus Vector, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Genetic Virus Vector.

The Genetic Virus Vector market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Genetic Virus Vector market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Genetic Virus Vector companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Genetic Virus Vector Market Report

Report Metric	Details
Report Name	Genetic Virus Vector Market
Segment by Type	Retroviral Vectors Adenoviral Vectors Adeno-Associated Viral Vectors Other
Segment by Application	Gene Therapy Vaccinology
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	FUJIFILM Diosynth Biotechnologies U.S.A., Sanofi, Lonza, Merck KGaA, GENERAL ELECTRIC COMPANY, Oxford BioMedica, Spark Therapeutics, Inc., uniQure N.V., FinVector Vision Therapies, Brammer Bio, Cell and Gene Therapy Catapult, Cobra Biologics, REGENXBIO Inc., Kaneka Eurogentec S.A.
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Genetic Virus Vector company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Genetic Virus Vector Market report?

Ans: The main players in the Genetic Virus Vector Market are FUJIFILM Diosynth Biotechnologies U.S.A., Sanofi, Lonza, Merck KGaA, GENERAL ELECTRIC COMPANY, Oxford BioMedica, Spark Therapeutics, Inc., uniQure N.V., FinVector Vision Therapies, Brammer Bio, Cell and Gene Therapy Catapult, Cobra Biologics, REGENXBIO Inc., Kaneka Eurogentec S.A.

What are the Application segmentation covered in the Genetic Virus Vector Market report?

Ans: The Applications covered in the Genetic Virus Vector Market report are Gene Therapy, Vaccinology

What are the Type segmentation covered in the Genetic Virus Vector Market report?

Ans: The Types covered in the Genetic Virus Vector Market report are Retroviral Vectors, Adenoviral Vectors, Adeno-Associated Viral Vectors, Other

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Genetic Virus Vector Market Size Growth Rate by Type: 2020 VS 2024 VS 2031

1.2.2 Retroviral Vectors

1.2.3 Adenoviral Vectors

1.2.4 Adeno-Associated Viral Vectors

1.2.5 Other

1.3 Market by Application

1.3.1 Global Genetic Virus Vector Market Growth by Application: 2020 VS 2024 VS 2031

1.3.2 Gene Therapy

1.3.3 Vaccinology

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global Genetic Virus Vector Market Perspective (2020-2031)

2.2 Global Genetic Virus Vector Growth Trends by Region

2.2.1 Global Genetic Virus Vector Market Size by Region: 2020 VS 2024 VS 2031

2.2.2 Genetic Virus Vector Historic Market Size by Region (2020-2025)

2.2.3 Genetic Virus Vector Forecasted Market Size by Region (2026-2031)

2.3 Genetic Virus Vector Market Dynamics

2.3.1 Genetic Virus Vector Industry Trends

2.3.2 Genetic Virus Vector Market Drivers

2.3.3 Genetic Virus Vector Market Challenges

2.3.4 Genetic Virus Vector Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Genetic Virus Vector Players by Revenue

3.1.1 Global Top Genetic Virus Vector Players by Revenue (2020-2025)

3.1.2 Global Genetic Virus Vector Revenue Market Share by Players (2020-2025)

3.2 Global Genetic Virus Vector Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Global Key Players Ranking by Genetic Virus Vector Revenue

3.4 Global Genetic Virus Vector Market Concentration Ratio

3.4.1 Global Genetic Virus Vector Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Genetic Virus Vector Revenue in 2024

3.5 Global Key Players of Genetic Virus Vector Head office and Area Served

3.6 Global Key Players of Genetic Virus Vector, Product and Application

3.7 Global Key Players of Genetic Virus Vector, Date of Enter into This Industry

3.8 Mergers & Acquisitions, Expansion Plans

4 Genetic Virus Vector Breakdown Data by Type

4.1 Global Genetic Virus Vector Historic Market Size by Type (2020-2025)

4.2 Global Genetic Virus Vector Forecasted Market Size by Type (2026-2031)

5 Genetic Virus Vector Breakdown Data by Application

5.1 Global Genetic Virus Vector Historic Market Size by Application (2020-2025)

5.2 Global Genetic Virus Vector Forecasted Market Size by Application (2026-2031)

6 North America

6.1 North America Genetic Virus Vector Market Size (2020-2031)

6.2 North America Genetic Virus Vector Market Growth Rate by Country: 2020 VS 2024 VS 2031

6.3 North America Genetic Virus Vector Market Size by Country (2020-2025)

6.4 North America Genetic Virus Vector Market Size by Country (2026-2031)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Genetic Virus Vector Market Size (2020-2031)

7.2 Europe Genetic Virus Vector Market Growth Rate by Country: 2020 VS 2024 VS 2031

7.3 Europe Genetic Virus Vector Market Size by Country (2020-2025)

7.4 Europe Genetic Virus Vector Market Size by Country (2026-2031)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific Genetic Virus Vector Market Size (2020-2031)

8.2 Asia-Pacific Genetic Virus Vector Market Growth Rate by Region: 2020 VS 2024 VS 2031

8.3 Asia-Pacific Genetic Virus Vector Market Size by Region (2020-2025)

8.4 Asia-Pacific Genetic Virus Vector Market Size by Region (2026-2031)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America Genetic Virus Vector Market Size (2020-2031)

9.2 Latin America Genetic Virus Vector Market Growth Rate by Country: 2020 VS 2024 VS 2031

9.3 Latin America Genetic Virus Vector Market Size by Country (2020-2025)

9.4 Latin America Genetic Virus Vector Market Size by Country (2026-2031)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Genetic Virus Vector Market Size (2020-2031)

10.2 Middle East & Africa Genetic Virus Vector Market Growth Rate by Country: 2020 VS 2024 VS 2031

10.3 Middle East & Africa Genetic Virus Vector Market Size by Country (2020-2025)

10.4 Middle East & Africa Genetic Virus Vector Market Size by Country (2026-2031)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 FUJIFILM Diosynth Biotechnologies U.S.A.

11.1.1 FUJIFILM Diosynth Biotechnologies U.S.A. Company Details

11.1.2 FUJIFILM Diosynth Biotechnologies U.S.A. Business Overview

11.1.3 FUJIFILM Diosynth Biotechnologies U.S.A. Genetic Virus Vector Introduction

11.1.4 FUJIFILM Diosynth Biotechnologies U.S.A. Revenue in Genetic Virus Vector Business (2020-2025)

11.1.5 FUJIFILM Diosynth Biotechnologies U.S.A. Recent Development

11.2 Sanofi

11.2.1 Sanofi Company Details

11.2.2 Sanofi Business Overview

11.2.3 Sanofi Genetic Virus Vector Introduction

11.2.4 Sanofi Revenue in Genetic Virus Vector Business (2020-2025)

11.2.5 Sanofi Recent Development

11.3 Lonza

11.3.1 Lonza Company Details

11.3.2 Lonza Business Overview

11.3.3 Lonza Genetic Virus Vector Introduction

11.3.4 Lonza Revenue in Genetic Virus Vector Business (2020-2025)

11.3.5 Lonza Recent Development

11.4 Merck KGaA

11.4.1 Merck KGaA Company Details

11.4.2 Merck KGaA Business Overview

11.4.3 Merck KGaA Genetic Virus Vector Introduction

11.4.4 Merck KGaA Revenue in Genetic Virus Vector Business (2020-2025)

11.4.5 Merck KGaA Recent Development

11.5 GENERAL ELECTRIC COMPANY

11.5.1 GENERAL ELECTRIC COMPANY Company Details

11.5.2 GENERAL ELECTRIC COMPANY Business Overview

11.5.3 GENERAL ELECTRIC COMPANY Genetic Virus Vector Introduction

11.5.4 GENERAL ELECTRIC COMPANY Revenue in Genetic Virus Vector Business (2020-2025)

11.5.5 GENERAL ELECTRIC COMPANY Recent Development

11.6 Oxford BioMedica

11.6.1 Oxford BioMedica Company Details

11.6.2 Oxford BioMedica Business Overview

11.6.3 Oxford BioMedica Genetic Virus Vector Introduction

11.6.4 Oxford BioMedica Revenue in Genetic Virus Vector Business (2020-2025)

11.6.5 Oxford BioMedica Recent Development

11.7 Spark Therapeutics, Inc.

11.7.1 Spark Therapeutics, Inc. Company Details

11.7.2 Spark Therapeutics, Inc. Business Overview

11.7.3 Spark Therapeutics, Inc. Genetic Virus Vector Introduction

11.7.4 Spark Therapeutics, Inc. Revenue in Genetic Virus Vector Business (2020-2025)

11.7.5 Spark Therapeutics, Inc. Recent Development

11.8 uniQure N.V.

11.8.1 uniQure N.V. Company Details

11.8.2 uniQure N.V. Business Overview

11.8.3 uniQure N.V. Genetic Virus Vector Introduction

11.8.4 uniQure N.V. Revenue in Genetic Virus Vector Business (2020-2025)

11.8.5 uniQure N.V. Recent Development

11.9 FinVector Vision Therapies

11.9.1 FinVector Vision Therapies Company Details

11.9.2 FinVector Vision Therapies Business Overview

11.9.3 FinVector Vision Therapies Genetic Virus Vector Introduction

11.9.4 FinVector Vision Therapies Revenue in Genetic Virus Vector Business (2020-2025)

11.9.5 FinVector Vision Therapies Recent Development

11.10 Brammer Bio

11.10.1 Brammer Bio Company Details

11.10.2 Brammer Bio Business Overview

11.10.3 Brammer Bio Genetic Virus Vector Introduction

11.10.4 Brammer Bio Revenue in Genetic Virus Vector Business (2020-2025)

11.10.5 Brammer Bio Recent Development

11.11 Cell and Gene Therapy Catapult

11.11.1 Cell and Gene Therapy Catapult Company Details

11.11.2 Cell and Gene Therapy Catapult Business Overview

11.11.3 Cell and Gene Therapy Catapult Genetic Virus Vector Introduction

11.11.4 Cell and Gene Therapy Catapult Revenue in Genetic Virus Vector Business (2020-2025)

11.11.5 Cell and Gene Therapy Catapult Recent Development

11.12 Cobra Biologics

11.12.1 Cobra Biologics Company Details

11.12.2 Cobra Biologics Business Overview

11.12.3 Cobra Biologics Genetic Virus Vector Introduction

11.12.4 Cobra Biologics Revenue in Genetic Virus Vector Business (2020-2025)

11.12.5 Cobra Biologics Recent Development

11.13 REGENXBIO Inc.

11.13.1 REGENXBIO Inc. Company Details

11.13.2 REGENXBIO Inc. Business Overview

11.13.3 REGENXBIO Inc. Genetic Virus Vector Introduction

11.13.4 REGENXBIO Inc. Revenue in Genetic Virus Vector Business (2020-2025)

11.13.5 REGENXBIO Inc. Recent Development

11.14 Kaneka Eurogentec S.A.

11.14.1 Kaneka Eurogentec S.A. Company Details

11.14.2 Kaneka Eurogentec S.A. Business Overview

11.14.3 Kaneka Eurogentec S.A. Genetic Virus Vector Introduction

11.14.4 Kaneka Eurogentec S.A. Revenue in Genetic Virus Vector Business (2020-2025)

11.14.5 Kaneka Eurogentec S.A. Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.1.1 Research Programs/Design

13.1.1.2 Market Size Estimation

13.1.1.3 Market Breakdown and Data Triangulation

13.1.2 Data Source

13.1.2.1 Secondary Sources

13.1.2.2 Primary Sources

13.2 Author Details

13.3 Disclaimer

FEATURED COMPANIES

Sanofi

Lonza

Merck KGaA

General Electric Company

Oxford BioMedica

Spark Therapeutics Inc

uniQure N.V.

FinVector Vision Therapies

Brammer Bio

Cell and Gene Therapy Catapult

Cobra Biologics

REGENXBIO

Kaneka Eurogentec S.A.

FUJIFILM Diosynth Biotechnologies U.S.A.

List of Tables

Table 1. Global Genetic Virus Vector Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031

Table 2. Key Players of Retroviral Vectors

Table 3. Key Players of Adenoviral Vectors

Table 4. Key Players of Adeno-Associated Viral Vectors

Table 5. Key Players of Other

Table 6. Global Genetic Virus Vector Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031

Table 7. Global Genetic Virus Vector Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 8. Global Genetic Virus Vector Market Size by Region (2020-2025) & (US$ Million)

Table 9. Global Genetic Virus Vector Market Share by Region (2020-2025)

Table 10. Global Genetic Virus Vector Forecasted Market Size by Region (2026-2031) & (US$ Million)

Table 11. Global Genetic Virus Vector Market Share by Region (2026-2031)

Table 12. Genetic Virus Vector Market Trends

Table 13. Genetic Virus Vector Market Drivers

Table 14. Genetic Virus Vector Market Challenges

Table 15. Genetic Virus Vector Market Restraints

Table 16. Global Genetic Virus Vector Revenue by Players (2020-2025) & (US$ Million)

Table 17. Global Genetic Virus Vector Market Share by Players (2020-2025)

Table 18. Global Top Genetic Virus Vector Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Genetic Virus Vector as of 2024)

Table 19. Ranking of Global Top Genetic Virus Vector Companies by Revenue (US$ Million) in 2024

Table 20. Global 5 Largest Players Market Share by Genetic Virus Vector Revenue (CR5 and HHI) & (2020-2025)

Table 21. Global Key Players of Genetic Virus Vector, Headquarters and Area Served

Table 22. Global Key Players of Genetic Virus Vector, Product and Application

Table 23. Global Key Players of Genetic Virus Vector, Date of Enter into This Industry

Table 24. Mergers & Acquisitions, Expansion Plans

Table 25. Global Genetic Virus Vector Market Size by Type (2020-2025) & (US$ Million)

Table 26. Global Genetic Virus Vector Revenue Market Share by Type (2020-2025)

Table 27. Global Genetic Virus Vector Forecasted Market Size by Type (2026-2031) & (US$ Million)

Table 28. Global Genetic Virus Vector Revenue Market Share by Type (2026-2031)

Table 29. Global Genetic Virus Vector Market Size by Application (2020-2025) & (US$ Million)

Table 30. Global Genetic Virus Vector Revenue Market Share by Application (2020-2025)

Table 31. Global Genetic Virus Vector Forecasted Market Size by Application (2026-2031) & (US$ Million)

Table 32. Global Genetic Virus Vector Revenue Market Share by Application (2026-2031)

Table 33. North America Genetic Virus Vector Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 34. North America Genetic Virus Vector Market Size by Country (2020-2025) & (US$ Million)

Table 35. North America Genetic Virus Vector Market Size by Country (2026-2031) & (US$ Million)

Table 36. Europe Genetic Virus Vector Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 37. Europe Genetic Virus Vector Market Size by Country (2020-2025) & (US$ Million)

Table 38. Europe Genetic Virus Vector Market Size by Country (2026-2031) & (US$ Million)

Table 39. Asia-Pacific Genetic Virus Vector Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031

Table 40. Asia-Pacific Genetic Virus Vector Market Size by Region (2020-2025) & (US$ Million)

Table 41. Asia-Pacific Genetic Virus Vector Market Size by Region (2026-2031) & (US$ Million)

Table 42. Latin America Genetic Virus Vector Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 43. Latin America Genetic Virus Vector Market Size by Country (2020-2025) & (US$ Million)

Table 44. Latin America Genetic Virus Vector Market Size by Country (2026-2031) & (US$ Million)

Table 45. Middle East & Africa Genetic Virus Vector Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 46. Middle East & Africa Genetic Virus Vector Market Size by Country (2020-2025) & (US$ Million)

Table 47. Middle East & Africa Genetic Virus Vector Market Size by Country (2026-2031) & (US$ Million)

Table 48. FUJIFILM Diosynth Biotechnologies U.S.A. Company Details

Table 49. FUJIFILM Diosynth Biotechnologies U.S.A. Business Overview

Table 50. FUJIFILM Diosynth Biotechnologies U.S.A. Genetic Virus Vector Product

Table 51. FUJIFILM Diosynth Biotechnologies U.S.A. Revenue in Genetic Virus Vector Business (2020-2025) & (US$ Million)

Table 52. FUJIFILM Diosynth Biotechnologies U.S.A. Recent Development

Table 53. Sanofi Company Details

Table 54. Sanofi Business Overview

Table 55. Sanofi Genetic Virus Vector Product

Table 56. Sanofi Revenue in Genetic Virus Vector Business (2020-2025) & (US$ Million)

Table 57. Sanofi Recent Development

Table 58. Lonza Company Details

Table 59. Lonza Business Overview

Table 60. Lonza Genetic Virus Vector Product

Table 61. Lonza Revenue in Genetic Virus Vector Business (2020-2025) & (US$ Million)

Table 62. Lonza Recent Development

Table 63. Merck KGaA Company Details

Table 64. Merck KGaA Business Overview

Table 65. Merck KGaA Genetic Virus Vector Product

Table 66. Merck KGaA Revenue in Genetic Virus Vector Business (2020-2025) & (US$ Million)

Table 67. Merck KGaA Recent Development

Table 68. GENERAL ELECTRIC COMPANY Company Details

Table 69. GENERAL ELECTRIC COMPANY Business Overview

Table 70. GENERAL ELECTRIC COMPANY Genetic Virus Vector Product

Table 71. GENERAL ELECTRIC COMPANY Revenue in Genetic Virus Vector Business (2020-2025) & (US$ Million)

Table 72. GENERAL ELECTRIC COMPANY Recent Development

Table 73. Oxford BioMedica Company Details

Table 74. Oxford BioMedica Business Overview

Table 75. Oxford BioMedica Genetic Virus Vector Product

Table 76. Oxford BioMedica Revenue in Genetic Virus Vector Business (2020-2025) & (US$ Million)

Table 77. Oxford BioMedica Recent Development

Table 78. Spark Therapeutics, Inc. Company Details

Table 79. Spark Therapeutics, Inc. Business Overview

Table 80. Spark Therapeutics, Inc. Genetic Virus Vector Product

Table 81. Spark Therapeutics, Inc. Revenue in Genetic Virus Vector Business (2020-2025) & (US$ Million)

Table 82. Spark Therapeutics, Inc. Recent Development

Table 83. uniQure N.V. Company Details

Table 84. uniQure N.V. Business Overview

Table 85. uniQure N.V. Genetic Virus Vector Product

Table 86. uniQure N.V. Revenue in Genetic Virus Vector Business (2020-2025) & (US$ Million)

Table 87. uniQure N.V. Recent Development

Table 88. FinVector Vision Therapies Company Details

Table 89. FinVector Vision Therapies Business Overview

Table 90. FinVector Vision Therapies Genetic Virus Vector Product

Table 91. FinVector Vision Therapies Revenue in Genetic Virus Vector Business (2020-2025) & (US$ Million)

Table 92. FinVector Vision Therapies Recent Development

Table 93. Brammer Bio Company Details

Table 94. Brammer Bio Business Overview

Table 95. Brammer Bio Genetic Virus Vector Product

Table 96. Brammer Bio Revenue in Genetic Virus Vector Business (2020-2025) & (US$ Million)

Table 97. Brammer Bio Recent Development

Table 98. Cell and Gene Therapy Catapult Company Details

Table 99. Cell and Gene Therapy Catapult Business Overview

Table 100. Cell and Gene Therapy Catapult Genetic Virus Vector Product

Table 101. Cell and Gene Therapy Catapult Revenue in Genetic Virus Vector Business (2020-2025) & (US$ Million)

Table 102. Cell and Gene Therapy Catapult Recent Development

Table 103. Cobra Biologics Company Details

Table 104. Cobra Biologics Business Overview

Table 105. Cobra Biologics Genetic Virus Vector Product

Table 106. Cobra Biologics Revenue in Genetic Virus Vector Business (2020-2025) & (US$ Million)

Table 107. Cobra Biologics Recent Development

Table 108. REGENXBIO Inc. Company Details

Table 109. REGENXBIO Inc. Business Overview

Table 110. REGENXBIO Inc. Genetic Virus Vector Product

Table 111. REGENXBIO Inc. Revenue in Genetic Virus Vector Business (2020-2025) & (US$ Million)

Table 112. REGENXBIO Inc. Recent Development

Table 113. Kaneka Eurogentec S.A. Company Details

Table 114. Kaneka Eurogentec S.A. Business Overview

Table 115. Kaneka Eurogentec S.A. Genetic Virus Vector Product

Table 116. Kaneka Eurogentec S.A. Revenue in Genetic Virus Vector Business (2020-2025) & (US$ Million)

Table 117. Kaneka Eurogentec S.A. Recent Development

Table 118. Research Programs/Design for This Report

Table 119. Key Data Information from Secondary Sources

Table 120. Key Data Information from Primary Sources

Table 121. Authors List of This Report

List of Figures

Figure 1. Genetic Virus Vector Picture

Figure 2. Global Genetic Virus Vector Market Size Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global Genetic Virus Vector Market Share by Type: 2024 VS 2031

Figure 4. Retroviral Vectors Features

Figure 5. Adenoviral Vectors Features

Figure 6. Adeno-Associated Viral Vectors Features

Figure 7. Other Features

Figure 8. Global Genetic Virus Vector Market Size by Application (2020-2031) & (US$ Million)

Figure 9. Global Genetic Virus Vector Market Share by Application: 2024 VS 2031

Figure 10. Gene Therapy Case Studies

Figure 11. Vaccinology Case Studies

Figure 12. Genetic Virus Vector Report Years Considered

Figure 13. Global Genetic Virus Vector Market Size (US$ Million), Year-over-Year: 2020-2031

Figure 14. Global Genetic Virus Vector Market Size, (US$ Million), 2020 VS 2024 VS 2031

Figure 15. Global Genetic Virus Vector Market Share by Region: 2024 VS 2031

Figure 16. Global Genetic Virus Vector Market Share by Players in 2024

Figure 17. Global Top Genetic Virus Vector Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Genetic Virus Vector as of 2024)

Figure 18. The Top 10 and 5 Players Market Share by Genetic Virus Vector Revenue in 2024

Figure 19. North America Genetic Virus Vector Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 20. North America Genetic Virus Vector Market Share by Country (2020-2031)

Figure 21. United States Genetic Virus Vector Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 22. Canada Genetic Virus Vector Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 23. Europe Genetic Virus Vector Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 24. Europe Genetic Virus Vector Market Share by Country (2020-2031)

Figure 25. Germany Genetic Virus Vector Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 26. France Genetic Virus Vector Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 27. U.K. Genetic Virus Vector Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 28. Italy Genetic Virus Vector Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 29. Russia Genetic Virus Vector Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 30. Nordic Countries Genetic Virus Vector Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 31. Asia-Pacific Genetic Virus Vector Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 32. Asia-Pacific Genetic Virus Vector Market Share by Region (2020-2031)

Figure 33. China Genetic Virus Vector Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 34. Japan Genetic Virus Vector Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 35. South Korea Genetic Virus Vector Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 36. Southeast Asia Genetic Virus Vector Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 37. India Genetic Virus Vector Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 38. Australia Genetic Virus Vector Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 39. Latin America Genetic Virus Vector Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 40. Latin America Genetic Virus Vector Market Share by Country (2020-2031)

Figure 41. Mexico Genetic Virus Vector Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 42. Brazil Genetic Virus Vector Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 43. Middle East & Africa Genetic Virus Vector Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 44. Middle East & Africa Genetic Virus Vector Market Share by Country (2020-2031)

Figure 45. Turkey Genetic Virus Vector Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 46. Saudi Arabia Genetic Virus Vector Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 47. UAE Genetic Virus Vector Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 48. FUJIFILM Diosynth Biotechnologies U.S.A. Revenue Growth Rate in Genetic Virus Vector Business (2020-2025)

Figure 49. Sanofi Revenue Growth Rate in Genetic Virus Vector Business (2020-2025)

Figure 50. Lonza Revenue Growth Rate in Genetic Virus Vector Business (2020-2025)

Figure 51. Merck KGaA Revenue Growth Rate in Genetic Virus Vector Business (2020-2025)

Figure 52. GENERAL ELECTRIC COMPANY Revenue Growth Rate in Genetic Virus Vector Business (2020-2025)

Figure 53. Oxford BioMedica Revenue Growth Rate in Genetic Virus Vector Business (2020-2025)

Figure 54. Spark Therapeutics, Inc. Revenue Growth Rate in Genetic Virus Vector Business (2020-2025)

Figure 55. uniQure N.V. Revenue Growth Rate in Genetic Virus Vector Business (2020-2025)

Figure 56. FinVector Vision Therapies Revenue Growth Rate in Genetic Virus Vector Business (2020-2025)

Figure 57. Brammer Bio Revenue Growth Rate in Genetic Virus Vector Business (2020-2025)

Figure 58. Cell and Gene Therapy Catapult Revenue Growth Rate in Genetic Virus Vector Business (2020-2025)

Figure 59. Cobra Biologics Revenue Growth Rate in Genetic Virus Vector Business (2020-2025)

Figure 60. REGENXBIO Inc. Revenue Growth Rate in Genetic Virus Vector Business (2020-2025)

Figure 61. Kaneka Eurogentec S.A. Revenue Growth Rate in Genetic Virus Vector Business (2020-2025)

Figure 62. Bottom-up and Top-down Approaches for This Report

Figure 63. Data Triangulation

Figure 64. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic

$2900

Single User License

Multi User

Electronic

$4350

Multi User License

Enterprise License

Electronic

$5800

Enterprise License

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions